Showing results (1651-1660 of 1,710) with videos related to
Sort By:
Pageof 171
Journal of Cancer Research and Clinical Oncology|December 4, 2022
Epirubicin, cisplatin plus ifosfamide versus standard chemotherapeutic regimens for advanced/unresectable primary thoracic sarcomasJeronimo Rafael Rodriguez-Cid, Juan Jose Juarez-Vignon Whaley, Gisela Sánchez-Domínguez, et al.Human Mutation|January 1, 1996
Germline mutations in the Von Hippel-Lindau disease (VHL) gene in families from North America, Europe, and JapanB Zbar, T Kishida, F Chen, et al.Journal of the Pediatric Infectious Diseases Society|September 1, 2021
Antigen Test Performance Among Children and Adults at a SARS-CoV-2 Community Testing SiteLaura Ford, Melissa J Whaley, Melisa M Shah, et al.Human Pathology|May 17, 2025
Evaluation of 3,606 renal cell tumors for TFE3 rearrangements and TFEB alterations via fluorescence in situ hybridization, next generation sequencing, and GPNMB immunohistochemistryRumeal D Whaley, Daniel R Sill, Burak Tekin, et al.ALTEX|April 10, 2021
Applying evidence-based methods to the development and use of adverse outcome pathwaysRob B M De Vries, Michelle Angrish, Patience Browne, et al.Journal of Clinical Epidemiology|August 6, 2025
GRADE Concept Paper 9: Rationale and process for creating a GRADE OntologyPaul Whaley, Brian S Alper, Joanne Dehnbostel, et al.Prostate Cancer and Prostatic Diseases|February 27, 2024
Genomic attributes of prostate cancer across primary and metastatic noncastrate and castrate resistant disease states: a next generation sequencing study of 183 patientsSurendra Dasari, Michael R McCarthy, Antonina A Wojcik, et al.Mayo Clinic Proceedings|February 13, 2026
Utility of Next-Generation Sequencing in Renal Neoplasia, Including Tumors With Clear Cytoplasm and Rare Phenotypes (ELOC/MITF Alterations and Mismatch Repair Deficiency)Michael McCarthy, Antonina A Wojcik, Emily G Barr Fritcher, et al.Environmental Health : a Global Access Science Source|July 15, 2016
A proposed framework for the systematic review and integrated assessment (SYRINA) of endocrine disrupting chemicalsLaura N Vandenberg, Marlene Ågerstrand, Anna Beronius, et al.Cancer Discovery|May 21, 2020
EGFR Blockade Reverts Resistance to KRASG12C Inhibition in Colorectal CancerVito Amodio, Rona Yaeger, Pamela Arcella, et al.Pageof 171